Fig. 3From: Patient-reported outcomes before treatment for localized prostate cancer: are there differences among countries? Data from the True North Global RegistryEPIC-26 domain scores of patients who underwent Brachytherapy (Italy did not have patients in this treatment group). Differences across countries were statistically significant only in the sexual (p = 0.006) and bowel (p = 0.0009) scores of EPIC-26. Legend: The upper and lower whiskers represent scores outside the middle 50%, but within 1.5 times the interquartile range above the upper quartile and below the lower quartile (Q1—1.5 * IQR or Q3 + 1.5 * IQR)Back to article page